# Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis

> **NCT00650078** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 350 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** MR prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00650078
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650078, "Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00650078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*